Chengda Pharmaceuticals Co Ltd. Stock Analysis 301201.SZ

Chengda Pharmaceuticals Co., Ltd. manufactures active pharmaceutical ingredients, food additives, fertilizer additives, antibiotics, and pharmaceutical intermediates. The company is headquartered in Jiaxing, Zhejiang and currently employs 659 full-time employees. The company went IPO on 2022-01-20. The firm is also engaged in the production and sales of L-carnitine series products and active pharmaceutical ingredients (APIs). The pharmaceutical intermediate products include NP0805/NP0908, NP1205, NP0806, NP1011/1214, NP1709 and others. The L-carnitine series products are used in the fields of food additives, feed additives and raw materials. The APIs products include Buwaxitan, Vidagliptin, Elagoli and others. The firm's products are exported to the United States, Europe, Japan, Canada, the United Kingdom, Italy and other countries and regions.